MetaADEDB 2.0 @ LMMD
Lutein
(KBPHJBAIARWVSC-RGZFRNHPSA-N)
Structure
SMILES
C/C(=C\C=C\C=C(\C=C\C=C(\C=C\C1=C(C)C[C@H](CC1(C)C)O)/C)/C)/C=C/C=C(/C=C/[C@H]1C(=C[C@@H](CC1(C)C)O)C)\C
Type(s)
Approved; Investigational; Nutraceutical
Molecular Formula:
C40H56O2
Molecular Weight:
568.871
Log P:
10.4033
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
127-40-2; 29414-89-9; 180580-60-3
Synonym(s)
1.
Lutein
2.
Lutein F
3.
Lutein G
4.
beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-
5.
beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-
6.
gamma Lutein
7.
Lutein, gamma
External Link(s)
MeSHD014975
PubChem Compound5281243
ChEBI28838
CHEMBLCHEMBL173929
DrugBankDB00137
DrugCentral4145
KEGGcpd:C08601
ZINC8221225
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgoraphobiaOFFSIDES
2AlveolitisOFFSIDES
3Anastomotic complicationOFFSIDES
4AphagiaOFFSIDES
5ArthritisOFFSIDES
6AtelectasisOFFSIDES
7AtopyOFFSIDES
8Biopsy endometrium abnormalOFFSIDES
9Bladder prolapseOFFSIDES
10Blood amylase increasedOFFSIDES
11Blood glucose abnormalOFFSIDES
12Blood urine presentOFFSIDES
13Blurred visionOFFSIDES
14Body TemperatureOFFSIDES
15BradycardiaOFFSIDES
16Breast cancer recurrentOFFSIDES
17BronchiectasisOFFSIDES
18BronchitisOFFSIDES
19Burning sensationOFFSIDES
20Cardioactive drug levelOFFSIDES
21Cardioactive drug level below therapeuticOFFSIDES
22CataractOFFSIDES
23Chemical and Drug Induced Liver Injury25815309CTD
24Choking sensationOFFSIDES
25Circumstance or information capable of leading to medication errorOFFSIDES
26Compression fractureOFFSIDES
27DehydrationOFFSIDES
28DrowsinessOFFSIDES
29Drug administration errorOFFSIDES
30Drug ineffectiveOFFSIDES
31Dry skinOFFSIDES
32Endometrial HyperplasiaOFFSIDES
33Endometrial cancer stage IIIOFFSIDES
34ErythemaOFFSIDES
35FatigueOFFSIDES
36Feeling abnormalOFFSIDES
37FibromyalgiaOFFSIDES
38GlaucomaOFFSIDES
39Hepatic cancer metastaticOFFSIDES
40Hepatitis B positiveOFFSIDES
41HysterectomyOFFSIDES
42LethargyOFFSIDES
43Leukemia L121018653355CTD
44Leukopenia neonatalOFFSIDES
45LipaseOFFSIDES
46Loose toothOFFSIDES
47LymphangitisOFFSIDES
48Malignant neoplasm of spinal cordOFFSIDES
49Mental status changesOFFSIDES
50Multiple MyelomaOFFSIDES
51Muscle WeaknessOFFSIDES
52Musculoskeletal PainOFFSIDES
53MyelodysplasiaOFFSIDES
54Necrosis26187899CTD
55NeuralgiaOFFSIDES
56Non-cardiac chest painOFFSIDES
57Oligospermia26187899CTD
58PleurisyOFFSIDES
59PneumothoraxOFFSIDES
60Polycystic Ovary Syndrome26545973CTD
61Post procedural complicationOFFSIDES
62Reduced dexterityOFFSIDES
63Respiratory FailureOFFSIDES
64Spinal claudicationOFFSIDES
65TendinitisOFFSIDES
66Transaminases increasedOFFSIDES
67UlcerOFFSIDES
68UrticariaCanada Vigilance: 1Canada Vigilance
69Uterine CancerOFFSIDES
70Uveitis22040935CTD
71Visual disturbanceOFFSIDES
72Vocal Cord ParalysisOFFSIDES
73Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.